Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.65
Bid: 37.20
Ask: 37.50
Change: -0.125 (-0.33%)
Spread: 0.30 (0.806%)
Open: 37.30
High: 37.65
Low: 37.00
Prev. Close: 37.475
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major Interest in Shares

23 Jun 2010 13:56

RNS Number : 1261O
Futura Medical PLC
23 June 2010
 



For immediate release

23 June 2010

 

Futura Medical plc

("Futura" or "the Group" or "the Company")

 

TR-1: Notification of major interests in shares

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Futura Medical plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

Brookwell Limited

4. Full name of shareholder(s)  (if different from 3.):

Nortrust Nominees Limited

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

22 June 2010

6. Date on which issuer notified:

23 June 2010

7. Threshold(s) that is/are crossed or reached:

 

3%

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

GB0033278473

2,128,835

2,128,835

1,778,835

Below 3%

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

 

Expiration date

 

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

 

% of voting rights

None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

 

 

Exercise price

 

Expiration date

 

Exercise/ Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

None

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

1,778,835

 

Below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

None

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Progressive AIM Realisation Limited is Investment Manager to Brookwell Limited.

 

14. Contact name:

Russell Scott

15. Contact telephone number:

020 7490 4355

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKKNDPBBKDPAB
Date   Source Headline
13th Sep 201911:46 amRNSHolding(s) in Company
12th Sep 20199:05 amRNSSecond Price Monitoring Extn
12th Sep 20199:00 amRNSPrice Monitoring Extension
11th Sep 20194:40 pmRNSSecond Price Monitoring Extn
11th Sep 20194:35 pmRNSPrice Monitoring Extension
11th Sep 20197:00 amRNSInterim Results for Six Months ended 30 June 2019
10th Sep 20197:00 amRNSFutura Announces Joint Venture Collaboration
16th Aug 20194:37 pmRNSHolding(s) in Company
12th Aug 20193:21 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSNotice of Interim Results
23rd Jul 20192:06 pmRNSSecond Price Monitoring Extn
23rd Jul 20192:00 pmRNSPrice Monitoring Extension
5th Jul 20193:54 pmRNSHolding(s) in Company
28th Jun 20194:40 pmRNSSecond Price Monitoring Extn
28th Jun 20194:36 pmRNSPrice Monitoring Extension
25th Jun 20194:47 pmRNSDirector/PDMR Shareholding
24th Jun 20194:42 pmRNSAGM Statement
24th Jun 20197:00 amRNSAGM Statement
19th Jun 20197:00 amRNSRecruitment completed for MED2005 Phase 3 study
30th May 20197:00 amRNSNotice of AGM
30th May 20197:00 amRNSBlock listing Interim Review
29th May 201910:47 amRNSHolding(s) in Company
23rd May 20197:00 amRNSLiberum Appointed as Nominated Adviser & Broker
8th May 20192:05 pmRNSSecond Price Monitoring Extn
8th May 20192:00 pmRNSPrice Monitoring Extension
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
3rd May 20192:05 pmRNSSecond Price Monitoring Extn
3rd May 20192:00 pmRNSPrice Monitoring Extension
16th Apr 20196:05 pmRNSHolding(s) in Company
10th Apr 20197:00 amRNSPreliminary Results for the year ended 31 Dec 2018
5th Mar 20197:00 amRNSNotice of Preliminary Results
20th Feb 20191:10 pmRNSHolding(s) in Company
14th Feb 20197:00 amRNSFutura to host EU Advisory Panel Meeting at ESSM
13th Feb 20195:04 pmRNSHolding(s) in Company
13th Feb 20194:40 pmRNSSecond Price Monitoring Extn
13th Feb 20194:35 pmRNSPrice Monitoring Extension
8th Feb 20199:55 amRNSHolding(s) in Company
6th Feb 20197:00 amRNSHolding(s) in Company
1st Feb 20197:00 amRNSTotal Voting Rights
28th Jan 20197:00 amRNSPresentation at the 21st ESSM Congress
23rd Jan 20195:38 pmRNSHolding(s) in Company
22nd Jan 201911:05 amRNSSecond Price Monitoring Extn
22nd Jan 201911:00 amRNSPrice Monitoring Extension
11th Jan 20193:56 pmRNSHolding(s) in Company
11th Jan 201911:01 amRNSRemuneration of Non-Executive Directors and TVR
8th Jan 201911:00 amRNSPrice Monitoring Extension
3rd Jan 20194:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20194:35 pmRNSPrice Monitoring Extension
17th Dec 20187:00 amRNSFutura Medical to Host R&D Day in February 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.